Rheumatology

Rheumatology


FOR EACH DISEASE, TRIO DEVELOPS A CUSTOM SOLUTION THAT CAPTURES PATIENT LEVEL DATA THROUGHOUT THE PATIENT JOURNEY, ALL IN REAL-TIME. TRIO’S COVERAGE INCLUDES APPROVED DRUG REGIMENS, PHYSICIANS AND PHARMACIES WITHOUT BIAS.

Data Sources for Rheumatology


Trio has developed a proprietary technology platform that redefines the approach and methodology of collecting retrospective observational data on real world patients.

Aggregate Disparate Data with PHI

Validate Every Patient – Adjudicate Each Data Field



Data Elements


DEMOGRAPHICS /
FAMILY HISTORY

  • Patient ID
  • Race
  • Employment Status
  • Occupation
  • Pharmacy 1, 2
  • Marital Status
  • Gender
  • Snowbird
  • Ethnicity

  • FAMILY HISTORY
  • Relationship
  • Age at Onset
  • Age at Death
  • Deceased Flag
  • Condition
  • Cause of Death

LABS

  • HbA1c
  • ESR (Sedimentation Rate)
  • Bilirubin
  • CRP
  • CBC with Differential
  • Complement C3
  • eGFR
  • Hematocrit
  • Platelets
  • Complement C4
  • HBV viral load
  • Uric Acid
  • ANA Screen
  • HCV viral load
  • Lipid Panel
  • RF Factor
  • TB tests

DISEASE ACTIVITY SCORES

  • Rapid 3
  • SLEDAI
  • BASDAI
  • TLAS
  • CDAI
  • HAQII
  • BASMI
  • FRAX
  • KOOS, JR.
  • DAS28
  • ASAS
  • FIQR
  • Grip Strength / Pain Score
  • DEXA Scans
  • JointExam
  • SDAI
  • PASI
  • Bone Density

CURRENT AND HISTORICAL MED AND DISPENSE INFO

  • Full Medication History
  • Name
  • Start Date
  • Stop Date
  • NDC Dispense(s)
  • Refill Number / Days Supplied
  • NDC Product Name(s)
  • Shipment Date(s)
  • Dispense Item Strength(s)







DIAGNOSTIC INFORMATION

  • Diagnostic Code Type
  • Diagnostic Code
  • Diagnosis Date






INSURANCE INFORMATION

  • Insurance Type

  • Out of Pocket Amount
  • Patient Assistance or
    Self Pay
  • Patient Assistance Amount
  • Copay Amount
  • Patient Copay
  • Type of Provider
  • City/State

FUTURE APPOINTMENTS

  • Appointment Date
  • Resource







ALLERGIES

  • Allergen
  • Patient ID
  • Onset Date
  • Reaction
  • Date Recorded
  • Date Resolved
  • Medication Name
  • Description
  • Type

Patient Tear Sheet


Real Time Aggregated Data is organized and visualized at a patient level for immediate and longitudinal insight.
Click on image below for a 3 page PDF of a Patient Tear Sheet.



Steering Committee


Colin C. Edgerton, MD

  • Chairman, Rheumatology Scientific Steering Committee, Trio Health
  • Physician at Articularis Healthcare
  • Executive Chair of the American Rheumatology Network
  • Assistant Professor of Medicine, Uniformed Services University of the Health Sciences
  • Holds national leadership positions in the ACR and in the American Medical Association

Kent “Kwas” Huston, MD

  • Physician at the Center for Rheumatic Disease, Kansas City Physician Partners
  • Clinical Assistant Professor, University of Missouri–Kansas City School of Medicine
  • Board of Directors Member, American College of Rheumatology (ACR)
  • Government Affairs Committee Member, American College of Rheumatology (ACR)

Simon Helfgott, MD

  • Associate Professor, Harvard Medical School, Division of Rheumatology and Immunology
  • Director of Education & Fellowship Training, Brigham and Women’s Hospital (BWH), Rheumatology
  • Co-Director of the Spine Center and Director of the Braintree Arthritis Center
  • Co-Director, Teaching of Rheumatic Diseases at Harvard Medical School

Jasvinder Singh, MD

  • Professor of Medicine and Epidemiology, Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham (UAB)
  • Director of the Gout Clinic at the UAB Health Sciences Foundation
  • National thought-leader of systematic reviews, meta-analyses and outcomes research in patients with rheumatic diseases

Nehad Solomon, MD, FACR, CPI

  • Medical Director of Arizona Arthritis Rheumatology Research
  • Associate Clinical Professor of Medicine,
    Midwestern University, AZCOM
  • President, Phoenix Rheumatology Association

Publication
Journals

  • New England Journal of Medicine
  • Lancet
  • Rheumatology
  • Journal of Rheumatology
  • Nature
  • Clinical Immunology


Associations and
Foundations

  • ACR
  • EULAR
  • PCORI
  • Arthritis Foundation



Advisory Board
Affiliations

  • Pfizer
  • Bristol Myers Squibb
  • Gilead
  • Janssen
  • Novartis
  • Roche
  • AbbVie
  • Eli Lilly

Publications


2021


Management of Gout after Pegloticase; Observations of US Clinical Practice from Trio Health and the American Rheumatology Network (ARN)

Nehad Soloman, Mona Amin, Simon Helfgott, Alexander Hu, Kent Kwas Huston, Jordan Leonard, Kelsey Milligan, Scott Milligan, Jasvinder Singh, John Tesser, and Colin Edgerton

ISPOR Presentations Database

Poster Presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

Conference dates: May 17, 2021 - May 20, 2021


Management of Gout with Pegloticase; Real-World Utilization and Outcomes from Trio Health and the American Rheumatology Network (ARN)

Nehad Soloman, Mona Amin, Kimmi Cox, Simon Helfgott, Alexander Hu, Kent Kwas Huston, Jordan Leonard, Scott Milligan, Jasvinder Singh, John Tesser, and Colin Edgerton

ISPOR Presentations Database

Poster Presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

Conference dates: May 17, 2021 - May 20, 2021


Real-World Utilization of Janus Kinase Inhibitors (JAKs) and Biologics in Patients with Rheumatoid Arthritis (RA)

Jasvinder A. Singh, MD, MPH, Janna Radtchenko, MBA, Nehad Soloman, MD, Kwas Huston, MD, Simon M. Helfgott, MD, and Colin C. Edgerton, MD

ISPOR Presentations Database

Poster Presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

Conference dates: May 17, 2021 - May 20, 2021


Increasing Use of Biologics in Treatment of Systemic Lupus Erythematosus Patients in US Clinical Practice: Real-World Observations from Trio Health and the American Rheumatology Network (ARN)

Simon Helfgott, Deepali Rane, Kent Kwas Huston, Jeremy Broestl, Jasvinder Singh, Nehad Soloman, and Colin Edgerton

ISPOR Presentations Database

Poster Presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

Conference dates: May 17, 2021 - May 20, 2021


Outcomes with Infliximab and Its Biosimilars in Patients with Rheumatoid Arthritis (RA): Real-World Experience in the US

Simon Helfgott, MD, Janna Radtchenko, MBA, Nehad Soloman, MD, Kent Kwas Huston, MD, Jasvinder Singh, MD, MPH, and Colin Edgerton, MD

ISPOR Presentations Database

Poster Presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

Conference dates: May 17, 2021 - May 20, 2021


Disparities in Targeted Immune Modulating (TIM) Treatment for Elderly Compared to Younger Patients with Psoriatic Arthritis (PSA)

Jasvinder Singh, Andrew Frick, Simon Helfgott, Kent Kwas Huston, Nehad Soloman, John Tesser, and Colin Edgerton

ISPOR Presentations Database

Poster Presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

Conference dates: May 17, 2021 - May 20, 2021


Experience with Apremilast in Treatment of Psoriatic Arthritis in US Clinical Practice; Assessments from Trio Health and the American Rheumatology Network (ARN)

Colin Edgerton, Andrew Frick, Simon Helfgott, Ken Kwas Huston, Jasvinder Singh, and Nehad Soloman

ISPOR Presentations Database

Poster Presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

Conference dates: May 17, 2021 - May 20, 2021


Real-World Utilization of Janus Kinase Inhibitors (JAKs) and Biologics in Patients with Rheumatoid Arthritis (RA)

Janna Radtchenko, Jasvinder A. Singh, MD, MPH, Nehad Soloman, MD, Kwas Huston, MD, Simon M. Helfgott, MD, and Colin C. Edgerton, MD

10.18553/jmcp.2021.27.4-a.s1

Poster Presented at: Academy of Managed Care Pharmacy (AMCP)

Conference dates: April 12, 2021 - April 16, 2021




2020


Real-World Utilization of Infliximab (IFX) and Its Biosimilars in Patients (Pts) with Rheumatoid Arthritis (RA) Since the First Biosimilar Approval in the US

Simon Helfgott, Janna Radtchenko, Nehad Soloman, Kent Kwas Huston, Jasvinder Singh, and Colin Edgerton

Arthritis Rheumatol. 2020; 72 (suppl 10)

Poster Presented at: ACR Convergence 2020

Conference dates: November 5, 2020 - November 9, 2020


Increasing Use of Biologics in Treatment of Systemic Lupus Erythematosus Patients in US Clinical Practice: Real-World Observations from Trio Health and the American Rheumatology Network

Simon Helfgott, Jeremy Broestl, Kent Kwas Huston, Deepali Rane, Jasvinder Singh, Nehad Soloman, and Colin Edgerton

Arthritis Rheumatol. 2020; 72 (suppl 10)

Poster Presented at: ACR Convergence 2020

Conference dates: November 5, 2020 - November 9, 2020


Management of Gout After Pegloticase; Observations of US Clinical Practice from Trio Health and the American Rheumatology Network (ARN)

Nehad Soloman, Mona Amin, Simon Helfgott, Alexander Hu, Kent Kwas Huston, Jordan Leonard, Kelsey Milligan, Scott Milligan, Jasvinder Singh, John Tesser, and Colin Edgerton

Arthritis Rheumatol. 2020; 72 (suppl 10)

Poster Presented at: ACR Convergence 2020

Conference dates: November 5, 2020 - November 9, 2020


Management of Gout with Pegloticase; Real-World Utilization and Outcomes from Trio Health and the American Rheumatology Network (ARN)

Nehad Soloman, Mona Amin, Kimmi Cox, Simon Helfgott, Alexander Hu, Kent Kwas Huston, Jordan Leonard, Scott Milligan, Jasvinder Singh, John Tesser, and Colin Edgerton

Arthritis Rheumatol. 2020; 72 (suppl 10)

Poster Presented at: ACR Convergence 2020

Conference dates: November 5, 2020 - November 9, 2020


Experience with Apremilast in Treatment of Psoriatic Arthritis in US Clinical Practice; Assessments from Trio Health and the American Rheumatology Network (ARN)

Colin Edgerton, Andrew Frick, Simon Helfgott, Kent Kwas Huston, Jasvinder Singh, and Nehad Soloman

Arthritis Rheumatol. 2020; 72 (suppl 10)

Poster Presented at: ACR Convergence 2020

Conference dates: November 5, 2020 - November 9, 2020


The “Why” of Drug Discontinuation; Clinical Review of EMR Notes for 2,545 Patients with Rheumatic Diseases

Kent Kwas Huston, Simon Helfgott, Scott Milligan, Jasvinder Singh, Nehad Soloman, Brandon Weil, and Colin Edgerton

Arthritis Rheumatol. 2020; 72 (suppl 10)

Poster Presented at: ACR Convergence 2020

Conference dates: November 5, 2020 - November 9, 2020


Change in Utilization of Outpatient Services at US Community Rheumatology Practices During COVID-19 Outbreak

Kent Kwas Huston, Nehad Soloman, Janna Radtchenko, Simon Helfgott, Jasvinder Singh, and Colin Edgerton

Arthritis Rheumatol. 2020; 72 (suppl 10)

Poster Presented at: ACR Convergence 2020

Conference dates: November 5, 2020 - November 9, 2020


Outpatient Costs in Rheumatoid Arthritis (RA) Patients With VS Without Comorbidities

Colin Edgerton, Janna Radtchenko, and V. Michael Holers

DOI: 10.1016/j.jval.2020.04.691

Poster Presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

Conference dates: May 18, 2020 - May 22, 2020




2019


Outpatient Costs and Evaluation and Management (E&M) Expenditure Trends in Rheumatoid Arthritis (RA) Patients Treated with Biologic Therapies in US Community Practices

Colin C. Edgerton, Janna Radtchenko, and V. Michael Holers

Arthritis Rheumatol. 2019; 71 (suppl 10): Abstract #1138

Poster Presented at: 2019 ACR/ARP Annual Meeting

Conference dates: November 8, 2019 - November 13, 2019